| Company | Pear Therapeutics |
|---|---|
| Date | 2023-04 |
| Industry | Healthcare |
| City | Boston |
| Country | United States |
| Employees Affected | 170 |
| % of Workforce | 92% |
| Status | Post-IPO |
| Company | Pear Therapeutics |
|---|---|
| Date | 2023-04 |
| Industry | Healthcare |
| City | Boston |
| Country | United States |
| Employees Affected | 170 |
| % of Workforce | 92% |
| Status | Post-IPO |